European Heart Journal Supplements

Papers
(The H4-Index of European Heart Journal Supplements is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review50
Long COVID: long-term effects?38
What do we do about atrial high rate episodes?36
Left ventricular unloading and the role of ECpella32
Atrial fibrillation in low- and middle-income countries: a narrative review29
Lipoprotein(a) and PCSK9 inhibition: clinical evidence24
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies24
Sympathetic activation in heart failure23
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal22
Atrial fibrillation: villain or bystander in vascular brain injury22
Coagulopathy and COVID-1921
The metaverse in medicine19
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction19
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations18
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications17
Infective endocarditis and neurologic events: indications and timing for surgical interventions17
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes17
0.056136846542358